You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 12, 2025

Industrialized, Artificial Intelligence-guided Laser Microdissection for Microscaled Proteomic Analysis of the Tumor Microenvironment
Published on: June 3, 2022
Frederick Klauschen1,2,3,4, Jonas Dippel3,5, Philipp Keyl1
1Institute of Pathology, Ludwig-Maximilians-Universität München, Munich, Germany;
This review explores how artificial intelligence can help pathologists analyze complex medical images and molecular data. It highlights the problem of opaque decision-making in standard computer models and introduces transparent methods to help doctors trust and understand machine-generated diagnostic results.
Area of Science:
Background:
Modern medicine faces significant hurdles when integrating massive histological image sets with diverse molecular datasets. Standard diagnostic workflows struggle to process these high-dimensional inputs in a uniform or quantitative manner. Deep learning architectures have emerged as powerful tools to address these complex analytical requirements. These computational systems assist with disease classification, biomarker quantification, and predicting patient outcomes. However, the opaque nature of conventional algorithmic decision-making creates a substantial barrier to clinical adoption. This lack of transparency prevents practitioners from verifying the logic behind automated diagnostic suggestions. That uncertainty drove the development of methods designed to clarify how models reach specific conclusions. No prior work had resolved the tension between high-performance predictive accuracy and the requirement for interpretability in clinical settings.
Purpose Of The Study:
The primary aim of this review is to foster a mutual understanding between the biomedical and computational sides of modern medicine. This work addresses the challenge of integrating large molecular profiling data into standard diagnostic pathology workflows. The authors seek to explain why conventional machine learning models often function as opaque black boxes. They intend to provide an overview of foundational concepts in both pathology and advanced computational technologies. The review explores how deep learning can facilitate complex tasks like tissue biomarker quantification and disease classification. By presenting worked-through examples, the researchers strive to improve the practical comprehension of what these tools can achieve. They aim to describe solutions that make algorithmic decisions more transparent for clinical users. This effort is motivated by the need to standardize and quantify diagnostic processes in an era of rapid technological development.
Main Methods:
The authors conduct a comprehensive literature synthesis to bridge the gap between biomedical diagnostics and computational science. Their review approach involves examining foundational concepts in both digital pathology and machine learning architectures. They evaluate the limitations of conventional opaque models by contrasting them with emerging transparent algorithmic frameworks. The investigation includes a detailed overview of how these systems process histological images and molecular datasets. To ensure practical relevance, the authors incorporate illustrative case studies that walk through specific analytical workflows. This methodology focuses on identifying how computational decisions can be made more accessible to human practitioners. They synthesize existing evidence to outline the current state of the field and its future requirements. The study design prioritizes clarity and conceptual alignment across distinct scientific disciplines.
Main Results:
The literature review indicates that deep learning technologies facilitate complex data analysis tasks including disease classification and tissue biomarker quantification. These computational systems demonstrate the potential to manage large molecular profiling datasets that currently challenge traditional diagnostic workflows. The authors report that standard models often function as black boxes, which limits their utility in clinical settings. They identify that transparent decision-making frameworks are required to address these interpretability concerns. The findings suggest that these new approaches allow for a more standardized and quantitative analysis of histological images. The authors highlight that integrating these tools can improve clinical outcome prediction accuracy. The synthesis shows that current developments are moving toward models that provide clearer insights into their internal logic. The evidence demonstrates that bridging the gap between biomedical and computational domains enhances the practical application of these advanced technologies.
Conclusions:
The authors propose that transparency is a prerequisite for the successful integration of automated tools into clinical practice. They suggest that interpretability methods allow clinicians to validate the logic behind algorithmic predictions. The review emphasizes that bridging the gap between biomedical expertise and computational science remains a priority. Researchers argue that moving away from opaque models will likely improve trust in digital diagnostic workflows. The synthesis indicates that explainable systems provide a pathway to standardize complex data analysis in pathology. They conclude that understanding the underlying mechanisms of these tools is as important as their predictive performance. The authors maintain that future progress depends on mutual comprehension between pathologists and computer scientists. This work highlights that clear communication regarding model behavior supports safer implementation of digital technologies in healthcare.
The researchers propose that explainable methods provide transparency by revealing the logic behind algorithmic predictions. Unlike standard black-box systems that hide their internal reasoning, these transparent approaches allow clinicians to verify how specific histological features influence a final diagnostic classification or biomarker quantification result.
The authors highlight deep learning as a primary technology for processing histological images and molecular profiles. These computational architectures are capable of handling high-dimensional data, which facilitates complex tasks like disease classification and clinical outcome prediction that were previously difficult to manage using traditional manual analysis techniques.
The authors suggest that interpretability is necessary because opaque models prevent practitioners from verifying the logic behind automated suggestions. Without this clarity, clinicians cannot safely trust or validate the outputs generated by complex algorithms, which hinders the adoption of these tools in high-stakes medical diagnostic environments.
The authors utilize worked-through examples to demonstrate how machine learning foundations apply to practical pathology. These illustrative cases serve as a bridge, helping biomedical professionals understand the mechanics of data integration and model training while highlighting the specific capabilities of current computational diagnostic tools.
The researchers measure the success of these systems by their ability to perform disease classification and biomarker quantification. These metrics demonstrate the potential of computational models to provide quantitative, standardized results that assist pathologists in analyzing increasingly large and complex molecular profiling datasets.
The authors propose that fostering a mutual understanding between biomedical experts and computer scientists is the primary implication of their work. They argue that this collaboration is essential for creating reliable, transparent, and clinically useful diagnostic tools that can effectively handle the demands of modern precision medicine.